We are a research-based specialty
biopharma company determined
to give people all over the world a
longer and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more


Scandinavian Biopharma

Scandinavian Biopharma announces marketing and distribution agreement with Emergent to relaunch the oral typhoid vaccine (Ty21a) in Germany

Scandinavian Biopharma has expanded the partnership with Emergent Travel Health Inc. to also include the marketing and distribution of Emergent’s oral typhoid vaccine (Ty21a) in Germany. Emergents oral typhoid vaccine will complement and s[...]
Read more


Scandinavian Biopharma

Scandinavian Biopharma extends its agreement with USAMMDA and obtains additional financial support

In 2020, Scandinavian Biopharma entered into an agreement with the United States Army Medical Materiel Development Activity (USAMMDA) to fund manufacturing and development activities for its ETEC diarrhoea vaccine, ETVAX®. The agreement has now[...]
Read more